Tulosta

Tavallisten haittavaikutusten ja yksilöllisten riskien huomiointi ADHD:n lääkehoidossa

Lisätietoa aiheesta
8.2.2017
Arja Voutilainen ja Anita Puustjärvi

Kirjallisuutta

  1. Hanc T, Cieslik J. Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches. Pediatrics 2008;121:e967-74 «PMID: 18381524»PubMed
  2. Hubel R, Jass J, Marcus A ym. Overweight and basal metabolic rate in boys with attention-deficit/hyperactivity disorder. Eat Weight Disord 2006;11:139-46 «PMID: 17075241»PubMed
  3. Faraone SV, Biederman J, Morley CP ym. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47:994-1009 «PMID: 18580502»PubMed
  4. Kidwell KM, Van Dyk TR, Lundahl A ym. Stimulant Medications and Sleep for Youth With ADHD: A Meta-analysis. Pediatrics 2015;136:1144-53 «PMID: 26598454»PubMed
  5. Paavonen J, Urrila AS. Unihäiriöt. Kirjassa Lastenpsykiatria ja Nuorisopsykiatria. Duodecim 2016:405-25
  6. Weiss MD, Wasdell MB, Bomben MM ym. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 2006;45:512-9 «PMID: 16670647»PubMed
  7. Sobanski E, Schredl M, Kettler N ym. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study. Sleep 2008;31:375-81 «PMID: 18363314»PubMed
  8. Ken Mehta S, Jacobs I. Stimulants for kids with ADHD--how to proceed safely. J Fam Pract 2014;63:E1-5 «PMID: 24527478»PubMed
  9. Samuels JA, Franco K, Wan F ym. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol 2006;21:92-5 «PMID: 16254730»PubMed
  10. Cooper WO, Habel LA, Sox CM ym. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011;365:1896-904 «PMID: 22043968»PubMed
  11. Habel LA, Cooper WO, Sox CM ym. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 2011;306:2673-83 «PMID: 22161946»PubMed
  12. Winterstein AG, Gerhard T, Kubilis P ym. Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. BMJ 2012;345:e4627 «PMID: 22809800»PubMed
  13. Cohen SC, Mulqueen JM, Ferracioli-Oda E ym. Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials. J Am Acad Child Adolesc Psychiatry 2015;54:728-36 «PMID: 26299294»PubMed
  14. Whittington C, Pennant M, Kendall T ym. Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review. J Child Psychol Psychiatry 2016;57:988-1004 «PMID: 27132945»PubMed
  15. Mosholder AD, Gelperin K, Hammad TA ym. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Pediatrics 2009;123:611-6 «PMID: 19171629»PubMed
  16. Man KK, Coghill D, Chan EW ym. Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system. Transl Psychiatry 2016;6:e956 «PMID: 27845780»PubMed
  17. Ross RG. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 2006;163:1149-52 «PMID: 16816217»PubMed
  18. Man KK, Coghill D, Chan EW ym. Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system. Transl Psychiatry 2016;6:e956 «PMID: 27845780»PubMed
  19. Santos K, Palmini A, Radziuk AL ym. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies. Dev Med Child Neurol 2013;55:654-60 «PMID: 23480530»PubMed
  20. Socanski D, Aurlien D, Herigstad A ym. Attention deficit/hyperactivity disorder and interictal epileptiform discharges: it is safe to use methylphenidate? Seizure 2015;25:80-3 «PMID: 25645642»PubMed
  21. Feuer AJ, Thai A, Demmer RT ym. Association of Stimulant Medication Use With Bone Mass in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. JAMA Pediatr 2016;170:e162804 «PMID: 27695823»PubMed
Käypä hoito -suositukset ovat riippumattomia, tutkimusnäyttöön perustuvia kansallisia hoitosuosituksia. Lue lisää
LINKKIEN TYYPIT JA VÄRIKOODIT
Kirjallisuusviite
Kuva
Linkki toiselle sivustolle
Lisätietoa
Näytönastekatsaus
PDF-tiedosto
PubMed-abstrakti
Taulukko